Hollywood Wants to Die on DEI Hill
It Was a Brutal Day for Mark Milley Who Lost More Than His...
Why Karoline Leavitt's First White House Press Briefing Was Pure Gold
The Chainsaw President!
Karoline Leavitt Confuses the Press by Showing Skill and Knowledge at Her First...
Disoriented Democrats Still Don't Know What Hit Them
CNN Anchor Can't Handle the Truth of Trump's New Polling High
Know Your Enemy
Trump's DEI Executive Order -- Good for Blacks, Good for America
Why Trump Wins: The Explanation For The Far-Left Intelligentsia And Haters
Tom Homan and Chris Stigall React To Selena Gomez Crying Over Deportations
California Up in Smoke, Thanks to Liberals
Designating Criminal Cartels as FTOs – Correct for Many Reasons
Don’t Ban TikTok Even Though They Banned Me
Pete Buttigieg Eyes Michigan Senate Seat: Is a Progressive Turn Coming for Michigan?
Tipsheet

'Revolving Door': What the WH Left Out of Its Announcement About Nominee for NIH Director

President Biden on Monday nominated Dr. Monica Bertagnolli, a surgical oncologist and head of the National Cancer Institute, to be the next director of the National Institutes of Health, but critics say the White House left out an important detail about her background in the administration’s announcement.  

Advertisement

“Dr. Bertagnolli has spent her career pioneering scientific discovery and pushing the boundaries of what is possible to improve cancer prevention and treatment for patients, and ensuring that patients in every community have access to quality care,” Biden said in a statement.
 
“As Director of the National Cancer Institute, Dr. Bertagnolli has advanced my Cancer Moonshot to end cancer as we know it. She has brought together partners and resources from different sectors to launch groundbreaking efforts in cancer prevention and early detection, a national navigation program for childhood cancers, and additional programs to bring clinical trials to more Americans,” the statement continued. “Dr. Bertagnolli is a world-class physician-scientist whose vision and leadership will ensure NIH continues to be an engine of innovation to improve the health of the American people.” 

As Democratic presidential candidate Robert F. Kennedy Jr. and others pointed out, she’s a “revolving door” nominee. 

“From 2015-2021, Bertagnolli received more than 116 grants from Pfizer, totaling $290.8 million. This amount made up 89% of all her. research grants,” he tweeted. 

Kennedy was sure to point out this doesn’t automatically make her “personally corrupt,” but that she will champion Big Pharma’s viewpoints.  

Advertisement

“That is how agencies are captured,” he added, commenting later that he was not surprised the White House left this detail out of the announcement. 


Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement